ESP Equity Partners

Founded in 2000, ESP Equity Partners is a private equity firm based in Bedminster, New Jersey. The firm focuses on acquiring pharmaceutical and medical assets in targeted therapeutic areas.

Douglas Sheldon

Co - Founder and Managing Partner

3 past transactions

EKR Therapeutics

Series D in 2008
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products specifically tailored for oncology supportive care and various acute-care hospital needs. EKR Therapeutics focuses on addressing a range of medical issues, including oral mucositis, stomatitis, dry mouth, nutritional challenges, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea. By providing effective treatment options, EKR Therapeutics aims to enhance the quality of life for cancer patients and those experiencing acute medical conditions.

EKR Therapeutics

Series C in 2007
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products specifically tailored for oncology supportive care and various acute-care hospital needs. EKR Therapeutics focuses on addressing a range of medical issues, including oral mucositis, stomatitis, dry mouth, nutritional challenges, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea. By providing effective treatment options, EKR Therapeutics aims to enhance the quality of life for cancer patients and those experiencing acute medical conditions.

EKR Therapeutics

Series B in 2006
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products specifically tailored for oncology supportive care and various acute-care hospital needs. EKR Therapeutics focuses on addressing a range of medical issues, including oral mucositis, stomatitis, dry mouth, nutritional challenges, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea. By providing effective treatment options, EKR Therapeutics aims to enhance the quality of life for cancer patients and those experiencing acute medical conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.